BR0314558A - Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas - Google Patents

Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas

Info

Publication number
BR0314558A
BR0314558A BR0314558-1A BR0314558A BR0314558A BR 0314558 A BR0314558 A BR 0314558A BR 0314558 A BR0314558 A BR 0314558A BR 0314558 A BR0314558 A BR 0314558A
Authority
BR
Brazil
Prior art keywords
polypeptides
processes
proteases
nucleic acids
acids encoding
Prior art date
Application number
BR0314558-1A
Other languages
English (en)
Inventor
Michelle Cayouette
Connie Jo Hansen
Amy Mcclure
May Sun
Svetlana Gramatikova
Mark Dycaico
Nelson Barton
Justin Stege
Nahla Aboushadi
Original Assignee
Diversa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diversa Corp filed Critical Diversa Corp
Publication of BR0314558A publication Critical patent/BR0314558A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Abstract

"PROTEASES, áCIDOS NUCLéICOS CODIFICANDO AS MESMAS E PROCESSOS PARA FABRICAçãO E USO DAS MESMAS". A presente invenção refere-se a polipeptídeos tendo atividade protease, polinucleotídeos codificando os polipeptídeos, e processos de fabricação e uso destes polinucleotídeos e polipeptídeos. Os polipeptídeos da invenção podem ser usados em uma variedade de contextos diagnósticos, terapêuticos e industriais. Os polipeptídeos da invenção podem ser usados como, por exemplo, um aditivo para um detergente, para processamento de alimentos e para sínteses químicas utilizando uma reação reversa. Adicionalmente, os polipeptídeos da invenção podem ser usados em processamento de alimento, cervejaria, aditivos de banho, produção de álcool, síntese de peptídeo, enantio - seletividade, preparação de couro na indústria de couros, gerenciamento de despejo e degradação animal, recuperação de prata na indústria fotográfica, tratamento médico, desengomação de seda, degradação de biofilme, conversão de biomassa a etanol, diodefense, agentes antimicrobiais e desinfetantes, cuidados pessoais e cosméticos, reagentes biotech, em aumento de rendimento de amido a partir de moagem úmida de milho e compostos farmacêuticos como auxiliares de digestão e agentes antiinflamatórios (antiflogísticos).
BR0314558-1A 2002-10-10 2003-10-10 Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas BR0314558A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41846702P 2002-10-10 2002-10-10
US47142303P 2003-05-16 2003-05-16
PCT/US2003/032819 WO2004033668A2 (en) 2002-10-10 2003-10-10 Proteases, nucleic acids encoding them and methods for making and using them

Publications (1)

Publication Number Publication Date
BR0314558A true BR0314558A (pt) 2005-08-09

Family

ID=32096250

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314558-1A BR0314558A (pt) 2002-10-10 2003-10-10 Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas

Country Status (9)

Country Link
US (1) US7642079B2 (pt)
EP (1) EP1578935A2 (pt)
JP (1) JP2006516889A (pt)
KR (1) KR20050052666A (pt)
AU (1) AU2003287105A1 (pt)
BR (1) BR0314558A (pt)
CA (1) CA2501645A1 (pt)
MX (1) MX282672B (pt)
WO (1) WO2004033668A2 (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360011A1 (en) * 1999-01-05 2000-07-13 Trustees Of Boston University Ordered gene assembly
US20040005673A1 (en) 2001-06-29 2004-01-08 Kevin Jarrell System for manipulating nucleic acids
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US7435562B2 (en) 2000-07-21 2008-10-14 Modular Genetics, Inc. Modular vector systems
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) * 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
JP3915983B2 (ja) 2003-05-27 2007-05-16 ゼライス株式会社 プロテアーゼ、このプロテアーゼをコードするｄｎａ、プロテアーゼの製造方法
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
DE102004019751A1 (de) * 2004-04-23 2005-11-17 Henkel Kgaa Neue Alkalische Proteasen und Wasch- und Reinigungsmittel, enthaltend diese neuen Alkalischen Proteasen
KR101264441B1 (ko) * 2004-10-18 2013-05-14 바스프 뷰티 케어 솔루션즈 프랑스 에스에이에스 올리고펩티드 및 그의 화장용 용도
CA2585098C (en) 2004-10-22 2018-12-18 Revivicor, Inc. Porcine genomic kappa and lambda light chain sequences
ATE540110T1 (de) 2004-11-11 2012-01-15 Modular Genetics Inc Oligonukleotid-leiterkonstruktion und system zur erzeugung von molekularer vielfalt
JP4485341B2 (ja) 2004-12-20 2010-06-23 花王株式会社 組換え微生物
AU2006262381A1 (en) * 2005-06-21 2007-01-04 Medimmune, Llc Methods and compositions for expressing negative-sense viral RNA in canine cells
CA2612806A1 (en) * 2005-06-24 2006-12-28 Solvay Pharmaceuticals Gmbh Proteases for pharmaceutical use
EP1920052A2 (en) * 2005-08-16 2008-05-14 Novozymes A/S Polypeptides of strain bacillus sp. p203
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
MX2008012999A (es) * 2006-04-14 2008-10-17 Genencor Int Tratamiento de una etapa de textiles.
WO2008056840A1 (en) * 2006-11-08 2008-05-15 Silla University Industry Academic Cooperation Foundation Fibrinolytic metalloprotease and composition comprising the same
DE102007033104A1 (de) * 2007-07-13 2009-01-15 Henkel Ag & Co. Kgaa Mittel enthaltend Proteasen aus Stenotrophomonas maltophilia
JP5260941B2 (ja) * 2007-11-15 2013-08-14 独立行政法人海洋研究開発機構 新規なコラーゲン分解酵素とその利用
JP5283154B2 (ja) * 2008-01-22 2013-09-04 長瀬産業株式会社 トリプシン様酵素
ES2330291B1 (es) * 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
EP2348827B1 (en) 2008-10-27 2015-07-01 Revivicor, Inc. Immunocompromised ungulates
WO2010068800A1 (en) * 2008-12-12 2010-06-17 Novozymes, Inc. Polypeptides having aspartic endopeptidase activity and polynucleotides encoding same
BRPI1007379B8 (pt) 2009-01-06 2022-07-19 Curemark Llc composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
CA2747611C (en) * 2009-01-06 2019-09-17 Curemark Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
AU2010205890B2 (en) * 2009-01-15 2015-01-15 Glutagen Pty Ltd Compositions for the treatment of gluten intolerance and uses thereof
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
WO2012030980A1 (en) * 2010-08-31 2012-03-08 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
KR101286733B1 (ko) * 2010-12-06 2013-07-16 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 세포표면에서 발현되는 항균 펩타이드 다중합체
MX2013009177A (es) * 2011-02-16 2013-08-29 Novozymes As Composiciones detergentes que comprenden metaloproteasas de m7 o m35.
WO2012154368A1 (en) * 2011-04-13 2012-11-15 The Trustees Of Columbia University In The City Of New York Precipatable peptipes
GB2503852B (en) 2011-04-21 2018-12-12 Curemark Llc Compounds for the treatment of neuropsychiatric disorders
WO2012155027A1 (en) 2011-05-12 2012-11-15 Healthpoint, Ltd. Wound debridement compositions containing seaprose and methods of wound treatment using same
US8329455B2 (en) 2011-07-08 2012-12-11 Aikan North America, Inc. Systems and methods for digestion of solid waste
ES2641039T3 (es) 2011-08-19 2017-11-07 Novozymes A/S Polipéptidos con actividad de proteasa
CN104114698A (zh) 2012-02-17 2014-10-22 诺维信公司 枯草杆菌蛋白酶变体以及编码它们的多核苷酸
CN104271726B (zh) * 2012-05-01 2018-08-24 诺维信公司 洗涤剂组合物
CA2872530A1 (en) 2012-05-11 2013-11-14 Smith & Nephew, Inc. Use of seaprose to remove bacterial biofilm
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
WO2014071410A1 (en) * 2012-11-05 2014-05-08 Danisco Us Inc. Compositions and methods comprising thermolysin protease variants
EP2735303A1 (en) 2012-11-23 2014-05-28 Pilosciences Hair growth compositions and methods
KR20140069867A (ko) * 2012-11-30 2014-06-10 대구대학교 산학협력단 유기화합물의 에스터결합 또는 단백질의 펩티드결합 가수분해용 산화-그래핀 및 그의 용도
JP6043371B2 (ja) * 2013-02-08 2016-12-14 国立大学法人福島大学 プロテアーゼ、プロテアーゼ含有洗浄剤及びその製造方法
DK2983497T3 (en) * 2013-03-11 2019-03-25 Bioresource Int Inc METHODS AND KITS FOR DETECTING PROTEASE ACTIVITY IN COMPLEX SAMPLES
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
CN103981164A (zh) * 2014-05-30 2014-08-13 华中农业大学 一种耐高温蛋白酶及其菌株选育方法和在酶解中的应用方法
US10947433B2 (en) * 2015-08-10 2021-03-16 Baker Hughes Holdings Llc Proteins for removing sulfurous compounds and/or acidic compounds in downhole fluids
WO2017027806A1 (en) 2015-08-13 2017-02-16 Coty Inc. Formulation and method for promoting cutaneous uptake of molecular oxygen by skin
KR20230047506A (ko) 2016-05-02 2023-04-07 엔코디아, 인코포레이티드 암호화 핵산을 사용한 거대분자 분석
CN109475609A (zh) 2016-07-27 2019-03-15 史密夫和内修有限公司 使用嗜热菌蛋白酶减少或消除来自表面的细菌生物膜
US10369190B2 (en) 2016-09-13 2019-08-06 Allergan, Inc. Non-protein clostridial toxin compositions
EP3573622B1 (en) 2017-01-30 2023-10-18 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
RU2019132448A (ru) * 2017-03-15 2021-04-15 ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС Способы применения сериновой протеазы архей
AU2018322865B2 (en) * 2017-09-01 2023-11-09 Novozymes A/S Animal feed additives comprising polypeptide having protease activity and uses thereof
SG11202003924YA (en) 2017-10-31 2020-05-28 Encodia Inc Kits for analysis using nucleic acid encoding and/or label
CN107927319B (zh) * 2017-12-26 2021-06-22 南京爱美倍健生物科技有限公司 一种利用花生固有蛋白酶水解花生蛋白制备花生多肽液的方法
SG11202110373WA (en) * 2019-03-26 2021-10-28 Encodia Inc Modified cleavases, uses thereof and related kits
US11427814B2 (en) 2019-03-26 2022-08-30 Encodia, Inc. Modified cleavases, uses thereof and related kits
JP2022530966A (ja) 2019-04-30 2022-07-05 エンコディア， インコーポレイテッド 分析物を調製するための方法および関連キット
US10515715B1 (en) 2019-06-25 2019-12-24 Colgate-Palmolive Company Systems and methods for evaluating compositions
KR102107812B1 (ko) * 2019-11-07 2020-05-07 주식회사 네이처센스 농업회사법인 인지기능 및 기억력 개선용 실크 유래 펩타이드의 제조방법
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
RU2768044C1 (ru) * 2021-12-28 2022-03-23 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Экспрессионный вектор на основе аденоассоциированного вируса, обладающий защитными свойствами против интоксикации, вызванной ботулиническим нейротоксином типа А
CN115532295B (zh) * 2022-09-27 2023-07-25 苏州大学 含有Zn-N-C活性中心的纳米材料在去除细菌生物膜中的应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261868A (en) * 1979-08-08 1981-04-14 Lever Brothers Company Stabilized enzymatic liquid detergent composition containing a polyalkanolamine and a boron compound
US4404128A (en) * 1981-05-29 1983-09-13 The Procter & Gamble Company Enzyme detergent composition
US5021246A (en) * 1984-03-30 1991-06-04 Anheuser-Busch, Incorporated Step mashing process for producing low alcohol beer
US5204015A (en) 1984-05-29 1993-04-20 Genencor International, Inc. Subtilisin mutants
US4677069A (en) * 1984-12-18 1987-06-30 Cornell Research Foundation, Inc. Clam derived proteinases
GB8724728D0 (en) * 1987-10-22 1987-11-25 Genzyme Corp Cysteine proteinase
US4788066A (en) * 1987-12-14 1988-11-29 Grain Processing Corporation Preparation of low alcohol beer
NL8902010A (nl) 1989-08-04 1991-03-01 Nl Zuivelonderzoek Inst Dna-fragment met ten minste een protease-gen, een dergelijk dna-fragment bevattende cloneringsvektor, een gastheercel getransformeerd met een dusdanig opgebouwde cloneringsvektor, alsmede de met dergelijke gastheercellen geproduceerde proteasen resp. bereide produkten zoals voedingsmiddelen.
US5024015A (en) * 1990-01-16 1991-06-18 Quarles Jr William B Lightweight articulated advertising display
US5326477A (en) * 1990-05-07 1994-07-05 Bio-Sep, Inc. Process for digesting solid waste
NL9100050A (nl) * 1991-01-11 1992-08-03 Heineken Technische Beheer Bv Werkwijze voor het continu bereiden van wort.
US5405624A (en) * 1991-02-14 1995-04-11 Bio-Technical Resources Process for producing a product with an intensified beer flavor
US5741693A (en) * 1992-07-02 1998-04-21 Novo Nordisk A/S Alkalophilic bacillus SP. AC13 and protease, xylanase, cellulase obtainable therefrom
CA2153163A1 (en) * 1992-12-31 1994-07-21 Klaus Dziondziak Process of producing beer
US6021536A (en) * 1993-03-04 2000-02-08 Wasinger; Eric Mechanical desizing and abrading device
BR9407834A (pt) * 1993-10-14 1997-05-13 Procter & Gamble Composições de limpeza contendo protease
CN1326994C (zh) * 1994-03-29 2007-07-18 诺沃奇梅兹有限公司 碱性芽孢杆菌淀粉酶
US5582681A (en) * 1994-06-29 1996-12-10 Kimberly-Clark Corporation Production of soft paper products from old newspaper
US6093562A (en) * 1996-02-05 2000-07-25 Novo Nordisk A/S Amylase variants
EP0835302A1 (en) 1995-06-28 1998-04-15 Novo Nordisk A/S A cellulase with reduced mobility
EP0839224A1 (en) * 1995-07-19 1998-05-06 Novo Nordisk A/S Treatment of fabrics
JP3626203B2 (ja) * 1995-11-15 2005-03-02 ノボザイムス アクティーゼルスカブ 染色されたデニムの複合糊抜及び「ストーンウォッシュ」方法
CN1209838A (zh) * 1996-01-29 1999-03-03 诺沃挪第克公司 纤维素织物的脱浆方法
US6197070B1 (en) * 1996-05-15 2001-03-06 The Procter & Gamble Company Detergent compositions comprising alpha combination of α-amylases for malodor stripping
WO1998006892A1 (en) * 1996-08-16 1998-02-19 International Paper Company Enzymatic freeness enhancement
US6326341B1 (en) * 1996-09-11 2001-12-04 The Procter & Gamble Company Low foaming automatic dishwashing compositions
AU4550997A (en) * 1996-10-11 1998-05-11 Novo Nordisk A/S Cellulose binding domains (cbds) for oral care products
US6069122A (en) * 1997-06-16 2000-05-30 The Procter & Gamble Company Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution
DE19703364A1 (de) * 1997-01-30 1998-08-06 Henkel Ecolab Gmbh & Co Ohg Pastenförmiges Wasch- und Reinigungsmittel
DE69833652T2 (de) * 1997-06-10 2006-09-21 Takara Bio Inc., Otsu System zum exprimieren einer hyperthermostabilen protease
US7049101B1 (en) * 1997-08-06 2006-05-23 Diversa Corporation Enzymes having high temperature polymerase activity and methods of use thereof
EP2388267A1 (en) * 1997-10-30 2011-11-23 Novozymes A/S Alpha-amylase mutants
CA2309252C (en) * 1997-11-10 2003-12-30 The Procter & Gamble Company Process for preparing a detergent tablet
US6187580B1 (en) * 1997-11-24 2001-02-13 Novo Nordisk A/S Pectate lyases
EP1082482A1 (en) * 1998-05-01 2001-03-14 Novozymes A/S Enhancers such as n-hydroxyacetanilide
DE19824705A1 (de) * 1998-06-03 1999-12-09 Henkel Kgaa Amylase und Protease enthaltende Wasch- und Reinigungsmittel
JP4335995B2 (ja) 1998-07-22 2009-09-30 昭 神谷 環境保全型粒状洗浄用組成物
US5980581A (en) * 1998-09-08 1999-11-09 The Virkler Company Process for desizing and cleaning woven fabrics and garments
AU6046199A (en) * 1998-09-17 2000-04-03 Novozymes North America, Inc. Methods for deinking and decolorizing printed paper
US6024766A (en) * 1999-01-27 2000-02-15 Wasinger; Eric M. Process for enzymatic desizing of garments and enzyme deactivation
US6309871B1 (en) * 1999-03-31 2001-10-30 Novozymes A/S Polypeptides having alkaline α-amylase activity
JP2005502310A (ja) * 2000-12-01 2005-01-27 ディヴァーサ コーポレイション ハイドロラーゼ酵素および速度論的分割における用途
WO2002072819A1 (fr) * 2001-03-14 2002-09-19 Takara Bio, Inc. Promoteurs

Also Published As

Publication number Publication date
WO2004033668A8 (en) 2008-06-05
CA2501645A1 (en) 2004-04-22
MX282672B (es) 2011-01-10
KR20050052666A (ko) 2005-06-03
EP1578935A2 (en) 2005-09-28
US20060259995A1 (en) 2006-11-16
US7642079B2 (en) 2010-01-05
AU2003287105A1 (en) 2004-05-04
MXPA05003763A (es) 2005-07-13
JP2006516889A (ja) 2006-07-13
WO2004033668A2 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
BR0314558A (pt) Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas
MA30063B1 (fr) Derives pyrimidinyl-aryluree constituant des inhibiteurs des facteurs de croissance des fibroblastes (fcg)
BR0007663A (pt) Derivados de acila para uso no tratamento de doenças relacionadas com o vla-4
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
ATE396973T1 (de) Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
BR0208150A (pt) Antagonistas de mch e sua aplicação no tratamento da obesidade
MA27608A1 (fr) Derives d'hydroxyethylamine utilises pour le traitement de la maladie d'alzheimer
BR0017050A (pt) Oxazolidinonas suebstituìdas e seu emprego na área da coagulação do sangue
ATE487493T1 (de) Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
EA200500472A1 (ru) Ацетил 2-гидрокси-1,3-диаминоалканы
TNSN02010A1 (fr) Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant
NO20014507D0 (no) Legemiddel for behandling av sukkersyke
MA27697A1 (fr) Derive de phenethanolamine utilise dans le traitement des maladies respiratoires
MA27316A1 (fr) Derives d'indoline-phenylsulfonamide
BG66080B1 (bg) Заместени тиоацетамиди
TNSN02032A1 (fr) Derives de glutaramide a substituant n-phenpropylcyclopentyle nouveaux, et compositions les contenant.
TR200003019T1 (tr) İkameli 2-fenil-1-(3,4-dihidroksi-5-nitrofenil)-1-etanonlar, bunları ihtiva eden farmasötik bileşimler
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
DE602006020898D1 (de) Peptide zur förderung des haarwachstums und zur verbesserung von falten und kosmetische zusammensetzungen, die diese enthalten
ATE517861T1 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
EA200401114A3 (ru) Замещённые гидроксиэтиламины
ATE446285T1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren
DK1264548T3 (da) Fysiologiske aktive midler indeholdende vicinale-dithioglykoler og anvendelse deraf i forskellige grene af erhvervssektoren
JP2009051813A5 (pt)
ITRM20020277A1 (it) Muteine del fattore di crescita placentare tipo 1, metodo di preparazione e loro applicazioni.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]